US20040089753A1
(en)
|
2000-06-28 |
2004-05-13 |
Holland Simon Joseph |
Wet milling process
|
AU2002246864A1
(en)
|
2000-12-27 |
2002-07-24 |
The Trustees Of Columbia University In The City Of New York |
Pim kinase-related methods
|
ES2365905T3
(es)
*
|
2001-03-30 |
2011-10-13 |
King Pharmaceuticals, Inc. |
Compuestos de tiofeno condensados y uso de los mismos en el tratamiento del dolor crónico.
|
DE10123055A1
(de)
|
2001-05-11 |
2003-03-20 |
Gruenenthal Gmbh |
Screeningverfahren mit PIM1-Kinase oder PIM3-Kinase
|
DE10226702A1
(de)
|
2002-06-14 |
2004-09-09 |
Grünenthal GmbH |
Antisense Oligonukleotide gegen PIM1
|
WO2004024895A2
(en)
|
2002-09-16 |
2004-03-25 |
Plexxikon, Inc. |
Crystal structure of pim-1 kinase
|
WO2006078228A1
(en)
|
2002-09-16 |
2006-07-27 |
Plexxikon, Inc. |
Methods for the design of molecular scaffolds and ligands
|
CL2003002287A1
(es)
|
2002-11-25 |
2005-01-14 |
Wyeth Corp |
COMPUESTOS DERIVADOS DE TIENO[3,2-b]-PIRIDINA-6-CARBONITRILOS Y TIENEO[2,3-b]-PIRIDINA-5-CARBONITRILOS, COMPOSICION FARMACEUTICA, PROCEDIMIENTO DE PREPARACION Y COMPUESTOS INTERMEDIARIOS, Y SU USO EN EL TRATAMIENTO DEL CANCER, APOPLEJIA, OSTEOPOROSIS
|
WO2004090106A2
(en)
|
2003-04-04 |
2004-10-21 |
Vertex Pharmaceuticals Incorporated |
Crystal structures of human pim-1 kinase protein complexes and binding pockets thereof, and uses thereof in drug design
|
US20050164300A1
(en)
|
2003-09-15 |
2005-07-28 |
Plexxikon, Inc. |
Molecular scaffolds for kinase ligand development
|
WO2005033310A1
(de)
|
2003-10-01 |
2005-04-14 |
Grünenthal GmbH |
Pim-1-spezifische dsrna-verbindungen
|
WO2006006569A1
(ja)
|
2004-07-12 |
2006-01-19 |
Nihon Nohyaku Co., Ltd. |
フェニルピリジン類又はその塩類、これらを有効成分とする除草剤及びその使用方法
|
PL1836169T3
(pl)
|
2004-12-28 |
2012-07-31 |
Kinex Pharmaceuticals Llc |
Kompozycje i sposoby leczenia zaburzeń związanych z proliferacją komórek
|
RS52010B
(en)
|
2005-06-22 |
2012-04-30 |
Plexxikon Inc. |
DERIVATI PIROLO [2, 3-B] PIRIDINA KAO INHIBITORI PROTEIN KINAZE
|
WO2007011760A2
(en)
|
2005-07-15 |
2007-01-25 |
Kalypsys, Inc. |
Inhibitors of mitotic kinesin
|
ATE411300T1
(de)
*
|
2005-08-05 |
2008-10-15 |
Hybrigenics Sa |
Neue cysteine protease hemmers und ihre therapeutische anwendungen
|
AR056206A1
(es)
|
2005-10-06 |
2007-09-26 |
Schering Corp |
Pirazolpirimidinas como inhibidores de protein quinasas
|
AU2006302174B2
(en)
|
2005-10-06 |
2013-06-20 |
Exelixis, Inc. |
Pyridopyrimidinone Inhibitors of PIM-1 and/or PIM-3
|
WO2007048065A2
(en)
|
2005-10-21 |
2007-04-26 |
Exelixis, Inc. |
Pyrimidinones as casein kinase ii (ck2) modulators
|
WO2007052843A1
(ja)
|
2005-11-04 |
2007-05-10 |
Takeda Pharmaceutical Company Limited |
複素環アミド化合物およびその用途
|
WO2007084857A2
(en)
|
2006-01-13 |
2007-07-26 |
President And Fellows Of Harvard College |
Methods and compositions for treating cell proliferative disorders
|
WO2007131191A2
(en)
|
2006-05-05 |
2007-11-15 |
Perkinelmer Life And Analytical Sciences |
Mass spectrometry methods for multiplexed quantification of protein kinases and phosphatases
|
CA2656564C
(en)
|
2006-06-29 |
2015-06-16 |
Kinex Pharmaceuticals, Llc |
Biaryl compositions and methods for modulating a kinase cascade
|
ES2500165T3
(es)
|
2006-06-29 |
2014-09-30 |
Kinex Pharmaceuticals, Llc |
Composiciones de biarilo y métodos para modular una cascada de quinasas
|
ATE517868T1
(de)
|
2006-08-16 |
2011-08-15 |
Boehringer Ingelheim Int |
Pyrazinverbindungen, ihre verwendung und herstellungsverfahren
|
WO2008045252A2
(en)
|
2006-10-04 |
2008-04-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Engineered integrin binding peptides
|
EP2078004B1
(en)
|
2006-10-31 |
2015-02-25 |
Merck Sharp & Dohme Corp. |
2-aminothiazole-4-carboxylic amides as protein kinase inhibitors
|
JP5357763B2
(ja)
|
2006-11-06 |
2013-12-04 |
トレロ ファーマシューティカルズ, インコーポレイテッド |
イミダゾ[1,2−b]ピリダジン誘導体およびピラゾロ[1,5−a]ピリダジン誘導体およびプロテインキナーゼインヒビターとしてのこれらの使用
|
WO2008082839A2
(en)
|
2006-12-29 |
2008-07-10 |
Abbott Laboratories |
Pim kinase inhibitors as cancer chemotherapeutics
|
WO2008082840A1
(en)
|
2006-12-29 |
2008-07-10 |
Abbott Laboratories |
Pim kinase inhibitors as cancer chemotherapeutics
|
MX2009009304A
(es)
|
2007-03-01 |
2009-11-18 |
Novartis Ag |
Inhibidores de cinasa pim y metodos para su uso.
|
JP2010522765A
(ja)
|
2007-03-28 |
2010-07-08 |
アレイ バイオファーマ、インコーポレイテッド |
受容体チロシンキナーゼとしてのイミダゾ[1,2−a]ピリジン化合物
|
JP5374492B2
(ja)
|
2007-04-03 |
2013-12-25 |
アレイ バイオファーマ、インコーポレイテッド |
受容体チロシンキナーゼ阻害薬としてのイミダゾ[1,2−a]ピリジン化合物
|
KR20100017359A
(ko)
|
2007-04-25 |
2010-02-16 |
엑셀리시스, 인코포레이티드 |
카제인 키나제 ⅱ (ck2)조절제로서의 피리미디논
|
CN102317266A
(zh)
|
2007-04-25 |
2012-01-11 |
埃克塞利希斯股份有限公司 |
作为pim调节剂的6-苯基嘧啶酮类
|
US8293747B2
(en)
|
2007-07-19 |
2012-10-23 |
Merck Sharp & Dohme Corp. |
Heterocyclic amide compounds as protein kinase inhibitors
|
RU2010106878A
(ru)
|
2007-07-31 |
2011-09-10 |
Шеринг Корпорейшн (US) |
Комбинация антимитотического агента и ингибитора аврора киназы как средство для лечения рака
|
TW200922557A
(en)
*
|
2007-08-06 |
2009-06-01 |
Janssen Pharmaceutica Nv |
Substituted phenylenediamines as inhibitors of the interaction between MDM2 and p53
|
CA2743756A1
(en)
|
2007-11-15 |
2009-05-22 |
Musc Foundation For Research Development |
Inhibitors of pim protein kinases, compositions, and methods for treating cancer
|
CA2705862C
(en)
|
2007-11-16 |
2018-03-27 |
San Diego State University Research Foundation |
Compositions and method for manipulating pim-1 activity in circulatory system cells
|
MX2010009445A
(es)
|
2008-02-29 |
2011-05-25 |
Cylene Pharmaceuticals Inc |
Moduladores de proteina kinasa.
|
AR070531A1
(es)
|
2008-03-03 |
2010-04-14 |
Novartis Ag |
Inhibidores de cinasa pim y metodos para su uso
|
US8168794B2
(en)
|
2008-03-03 |
2012-05-01 |
Novartis Ag |
Pim kinase inhibitors and methods of their use
|
EP2296472A4
(en)
|
2008-05-12 |
2011-06-08 |
Amnestix Inc |
COMPOUNDS FOR RHO KINASE INHIBITION AND FOR LEARNING AND REMINDERING IMPROVEMENT
|
EP2307421A4
(en)
|
2008-06-30 |
2011-07-13 |
Cylene Pharmaceuticals Inc |
OXINDOLE COMPOUNDS
|
UY31952A
(es)
|
2008-07-02 |
2010-01-29 |
Astrazeneca Ab |
5-metilideno-1,3-tiazolidina-2,4-dionas sustituidas como inhibidores de quinasa pim
|
FR2933409B1
(fr)
|
2008-07-03 |
2010-08-27 |
Centre Nat Rech Scient |
NOUVEAUX PYRROLO °2,3-a! CARBAZOLES ET LEUR UTILISATION COMME INHIBITEURS DES KINASES PIM
|
WO2010022081A1
(en)
|
2008-08-19 |
2010-02-25 |
Array Biopharma Inc. |
Triazolopyridine compounds as pim kinase inhibitors
|
TWI496779B
(zh)
|
2008-08-19 |
2015-08-21 |
Array Biopharma Inc |
作為pim激酶抑制劑之***吡啶化合物
|
KR20110058866A
(ko)
|
2008-09-02 |
2011-06-01 |
노파르티스 아게 |
비시클릭 키나제 억제제
|
CN102197032B
(zh)
|
2008-09-02 |
2014-07-23 |
诺华股份有限公司 |
杂环pim-激酶抑制剂
|
CN104311480A
(zh)
|
2008-09-02 |
2015-01-28 |
诺华股份有限公司 |
作为激酶抑制剂的吡啶甲酰胺衍生物
|
TWI458729B
(zh)
|
2008-10-22 |
2014-11-01 |
Array Biopharma Inc |
作為TRK激酶抑制劑之經取代吡唑并〔1,5-a〕嘧啶化合物
|
GB0821307D0
(en)
|
2008-11-21 |
2008-12-31 |
Summit Corp Plc |
Compounds for treatment of duchenne muscular dystrophy
|
ES2539620T3
(es)
|
2008-12-19 |
2015-07-02 |
Cephalon, Inc. |
Pirrolotriazina como inhibidor de ALK y de JAK2
|
WO2010123919A2
(en)
*
|
2009-04-20 |
2010-10-28 |
Auspex Pharmaceuticals, Llc |
Piperidine inhibitors of janus kinase 3
|
US20120128631A1
(en)
|
2009-05-19 |
2012-05-24 |
San Diego State University (SDSU) Foundation, dba San Diego State University (SDSU) Research |
Compositions and methods for kinase-mediated cytoprotection and enhanced cellular engraftment and persistence
|
EP2432473A4
(en)
|
2009-05-20 |
2013-12-11 |
Cylene Pharmaceuticals Inc |
PYRAZOLOPYRIMIDINES AND HETEROCYCLES ASSOCIATED AS KINASE INHIBITORS
|
WO2010135571A1
(en)
|
2009-05-20 |
2010-11-25 |
Cylene Pharmaceuticals, Inc. |
Novel protein kinase modulators
|
NZ596479A
(en)
|
2009-05-22 |
2014-01-31 |
Incyte Corp |
N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
|
WO2010148351A1
(en)
|
2009-06-18 |
2010-12-23 |
Cylene Pharmaceuticals, Inc. |
Rhodanines and related heterocycles as kinase inhibitors
|
EP2845856A1
(en)
|
2009-06-29 |
2015-03-11 |
Incyte Corporation |
Pyrimidinones as PI3K inhibitors
|
US20110065698A1
(en)
|
2009-08-26 |
2011-03-17 |
Cylene Pharmaceuticals, Inc. |
Novel protein kinase modulators
|
US9249145B2
(en)
|
2009-09-01 |
2016-02-02 |
Incyte Holdings Corporation |
Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
|
ES2557316T3
(es)
|
2009-09-08 |
2016-01-25 |
F. Hoffmann-La Roche Ag |
Compuestos de piridín-3-il-carboxamida 4-sustituidos y métodos de utilización
|
US8435976B2
(en)
|
2009-09-08 |
2013-05-07 |
F. Hoffmann-La Roche |
4-substituted pyridin-3-yl-carboxamide compounds and methods of use
|
CA2773854A1
(en)
|
2009-09-11 |
2011-03-17 |
Cylene Pharmaceuticals Inc. |
Pharmaceutically useful heterocycle-substituted lactams
|
IN2012DN03217A
(es)
|
2009-09-16 |
2015-10-23 |
Cylene Pharmaceuticals Inc |
|
CN102647906A
(zh)
|
2009-09-16 |
2012-08-22 |
赛林药物股份有限公司 |
三环化合物及其药学用途
|
KR101690358B1
(ko)
|
2009-10-29 |
2017-01-09 |
제노스코 |
키나아제 억제제
|
EP2332917B1
(en)
|
2009-11-11 |
2012-08-01 |
Sygnis Bioscience GmbH & Co. KG |
Compounds for PIM kinase inhibition and for treating malignancy
|
EP2499117B1
(en)
|
2009-11-12 |
2015-10-21 |
Selvita S.A. |
A compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent
|
KR101663637B1
(ko)
|
2009-11-13 |
2016-10-07 |
제노스코 |
키나아제 억제제
|
US8853235B2
(en)
|
2009-11-23 |
2014-10-07 |
Senhwa Biosciences, Inc. |
Polymorphs and salts of a kinase inhibitor
|
CA2782684C
(en)
|
2009-12-04 |
2018-09-04 |
Mustapha Haddach |
Pyrazolopyrimidines and related heterocycles as ck2 inhibitors
|
US8680108B2
(en)
|
2009-12-18 |
2014-03-25 |
Incyte Corporation |
Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors
|
WO2011075643A1
(en)
|
2009-12-18 |
2011-06-23 |
Incyte Corporation |
Substituted heteroaryl fused derivatives as pi3k inhibitors
|
WO2011075613A1
(en)
|
2009-12-18 |
2011-06-23 |
Sanofi |
Azaindole derivatives, their preparation and their therapeutic application
|
EP2516425B1
(en)
|
2009-12-23 |
2015-09-02 |
Jasco Pharmaceuticals LLC |
Aminopyrimidine kinase inhibitors
|
GB201002861D0
(en)
|
2010-02-19 |
2010-04-07 |
Cxr Biosciences Ltd |
Compositions
|
SG183551A1
(en)
|
2010-03-10 |
2012-10-30 |
Incyte Corp |
Piperidin-4-yl azetidine derivatives as jak1 inhibitors
|
MX2012011533A
(es)
|
2010-04-07 |
2012-12-17 |
Hoffmann La Roche |
Compuestos de pirazol-4-il-heterociclil-carboxamida y metodos de uso.
|
AR081823A1
(es)
|
2010-04-14 |
2012-10-24 |
Incyte Corp |
DERIVADOS FUSIONADOS COMO INHIBIDORES DE PI3Kd
|
US9062055B2
(en)
|
2010-06-21 |
2015-06-23 |
Incyte Corporation |
Fused pyrrole derivatives as PI3K inhibitors
|
US20130109682A1
(en)
|
2010-07-06 |
2013-05-02 |
Novartis Ag |
Cyclic ether compounds useful as kinase inhibitors
|
CN110003219A
(zh)
|
2010-07-13 |
2019-07-12 |
弗·哈夫曼-拉罗切有限公司 |
作为irak4调节剂的吡唑并[1,5a]嘧啶和噻吩并[3,2b]嘧啶衍生物
|
PT2598483T
(pt)
|
2010-07-29 |
2020-10-12 |
Rigel Pharmaceuticals Inc |
Compostos heterocíclicos de ativação de ampk e métodos de utilização dos mesmos
|
US8227773B2
(en)
|
2010-07-29 |
2012-07-24 |
Axcelis Technologies, Inc. |
Versatile beam glitch detection system
|
WO2012064981A2
(en)
|
2010-11-10 |
2012-05-18 |
National Jewish Health |
Methods to test allergic conditions
|
WO2012065297A1
(en)
|
2010-11-16 |
2012-05-24 |
Impact Therapeutics, Inc. |
3-ARYL-6-ARYL-[1,2,4]TRIAZOLO[4,3-a]PYRIDINES AS INHIBITORS OF CELL PROLIFERATION AND THE USE THEREOF
|
UA113156C2
(xx)
|
2010-11-19 |
2016-12-26 |
|
Циклобутилзаміщені похідні піролопіридину й піролопіримідину як інгібітори jak
|
US9034884B2
(en)
|
2010-11-19 |
2015-05-19 |
Incyte Corporation |
Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as JAK inhibitors
|
EP2649065A1
(en)
|
2010-12-09 |
2013-10-16 |
Amgen Inc. |
Bicyclic compounds as pim inhibitors
|
RU2652638C2
(ru)
|
2010-12-17 |
2018-04-28 |
НЕРВИАНО МЕДИКАЛ САЙЕНСИЗ С.р.л. |
Замещенные пиразолхиназолиновые производные в качестве ингибиторов киназы
|
US9096600B2
(en)
|
2010-12-20 |
2015-08-04 |
Incyte Corporation |
N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors
|
US8916577B2
(en)
|
2011-01-26 |
2014-12-23 |
Nerviano Medical Sciences S.R.L. |
Tricyclic derivatives, process for their preparation and their use as kinase inhibitors
|
CN103339134B
(zh)
|
2011-01-26 |
2015-12-23 |
内尔维阿诺医学科学有限公司 |
三环吡咯并衍生物、它们的制备方法和它们作为激酶抑制剂的应用
|
PL2678329T3
(pl)
|
2011-02-25 |
2016-06-30 |
Array Biopharma Inc |
Związki triazolopirydyny jako inhibitory kinaz pim
|
UY33930A
(es)
|
2011-03-04 |
2012-10-31 |
Novartis Ag |
Inhibidores novedosos de quinasas
|
JP2014506915A
(ja)
|
2011-03-04 |
2014-03-20 |
ノバルティス アーゲー |
キナーゼ阻害剤としての四置換シクロヘキシル化合物
|
US9108984B2
(en)
|
2011-03-14 |
2015-08-18 |
Incyte Corporation |
Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors
|
MX2013010771A
(es)
|
2011-03-22 |
2014-01-31 |
Amgen Inc |
Compuestos de azoles como inhibidores.
|
US9126948B2
(en)
|
2011-03-25 |
2015-09-08 |
Incyte Holdings Corporation |
Pyrimidine-4,6-diamine derivatives as PI3K inhibitors
|
WO2012137089A1
(en)
|
2011-04-05 |
2012-10-11 |
Pfizer Limited |
Pyrrolo [2, 3 -d] pyrimidine derivatives as inhibitors of tropomyosin- related kinases
|
US9284298B2
(en)
|
2011-04-11 |
2016-03-15 |
Nerviano Medical Sciences S.R.L. |
Pyrazolyl-pyrimidine derivatives as kinase inhibitors
|
WO2012145617A2
(en)
|
2011-04-22 |
2012-10-26 |
Jasco Pharmaceuticals, LLC |
Aminopyrimidine kinase inhibitors
|
GB201107176D0
(en)
|
2011-04-28 |
2011-06-15 |
Cxr Biosciences Ltd |
Pyrrolnitrin derivatives
|
GB201107197D0
(en)
|
2011-04-28 |
2011-06-15 |
Cxr Biosciences Ltd |
Compounds
|
US9187486B2
(en)
|
2011-04-29 |
2015-11-17 |
Amgen Inc. |
Bicyclic pyridazine compounds as Pim inhibitors
|
EP2710004A1
(en)
|
2011-05-17 |
2014-03-26 |
Bayer Intellectual Property GmbH |
Amino-substituted imidazopyridazines as mknk1 kinase inhibitors
|
RU2598840C2
(ru)
|
2011-05-19 |
2016-09-27 |
Фундасион Сентро Насиональ Де Инвестигасионес Онколохикас Карлос Iii |
Новые соединения
|
EP2714048A4
(en)
|
2011-05-27 |
2014-11-05 |
Univ Temple |
SUBSTITUTED 2-BENZYLIDENE-2H-BENZO [B] [1,4] THIAZIN-3 (4H) -ONES, DERIVED THEREFROM, AND THEIR THERAPEUTIC USES
|
EP2714692B1
(en)
|
2011-06-01 |
2017-03-22 |
Bayer Intellectual Property GmbH |
Substituted aminoimidazopyridazines
|
WO2012170827A2
(en)
|
2011-06-08 |
2012-12-13 |
Cylene Pharmaceuticals, Inc. |
Pyrazolopyrimidines and related heterocycles as ck2 inhibitors
|
JP5876146B2
(ja)
|
2011-06-20 |
2016-03-02 |
インサイト・ホールディングス・コーポレイションIncyte Holdings Corporation |
Jak阻害剤としてのアゼチジニルフェニル、ピリジル、またはピラジニルカルボキサミド誘導体
|
US9284319B2
(en)
|
2011-06-22 |
2016-03-15 |
Bayer Intellectual Property Gmbh |
Heterocyclyl aminoimidazopyridazines
|
JP6105578B2
(ja)
|
2011-07-21 |
2017-03-29 |
トレロ ファーマシューティカルズ, インコーポレイテッド |
複素環式プロテインキナーゼ阻害剤
|
CN102924446B
(zh)
|
2011-08-11 |
2015-08-26 |
上海吉铠医药科技有限公司 |
Pim激酶抑制剂及其制备方法与在制药中的应用
|
WO2013024002A1
(en)
|
2011-08-12 |
2013-02-21 |
F. Hoffmann-La Roche Ag |
PYRAZOLO[3,4-c]PYRIDINE COMPOUNDS AND METHODS OF USE
|
TW201313721A
(zh)
|
2011-08-18 |
2013-04-01 |
Incyte Corp |
作為jak抑制劑之環己基氮雜環丁烷衍生物
|
BR112014004971B1
(pt)
*
|
2011-09-02 |
2021-02-09 |
Incyte Holdings Corporation |
compostos heterociclilaminas, sua composição farmacêutica e seus usos
|
JP5843524B2
(ja)
|
2011-09-02 |
2016-01-13 |
キヤノン株式会社 |
有機無機複合組成物、有機無機複合材料、光学素子および積層型回折光学素子
|
UA117092C2
(uk)
|
2011-09-06 |
2018-06-25 |
Байєр Інтеллектуал Проперті Гмбх |
Амінозаміщені імідазопіридазини
|
UA111854C2
(uk)
|
2011-09-07 |
2016-06-24 |
Інсайт Холдінгс Корпорейшн |
Способи і проміжні сполуки для отримання інгібіторів jak
|
US8735528B1
(en)
*
|
2011-09-20 |
2014-05-27 |
The United States Of America As Represented By The Secretary Of The Air Force |
Two-photon absorbing cross-linked polyurethanes containing diphenylamino-dialkylfluorene-1,3,5-triazine units
|
WO2013041634A1
(en)
|
2011-09-23 |
2013-03-28 |
Bayer Intellectual Property Gmbh |
Substituted imidazopyridazines
|
CA2845191A1
(en)
|
2011-09-27 |
2013-04-04 |
F. Hoffmann-La Roche Ag |
Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
|
WO2013050446A1
(en)
|
2011-10-07 |
2013-04-11 |
Nerviano Medical Sciences S.R.L. |
SUBSTITUTED 3,4-DIHYDROPYRROLO[1,2-a]PYRAZIN-1(2H)-ONE DERIVATIVES AS KINASES INHIBITORS
|
JP6063945B2
(ja)
|
2011-10-07 |
2017-01-18 |
ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ |
キナーゼ阻害剤としての4−アルキル置換3,4−ジヒドロピロロ[1,2−a]ピラジン−1(2H)−オン誘導体
|
RU2674017C2
(ru)
|
2011-11-04 |
2018-12-04 |
ДЖАСКО ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи |
Аминопиримидиновые ингибиторы киназ
|
TW201348226A
(zh)
|
2012-02-28 |
2013-12-01 |
Amgen Inc |
作為pim抑制劑之醯胺
|
EP2822944A1
(en)
|
2012-03-05 |
2015-01-14 |
Amgen, Inc. |
Oxazolidinone compounds and derivatives thereof
|
EP2858993B1
(en)
|
2012-03-29 |
2018-01-10 |
Bayer Intellectual Property GmbH |
Amino-substituted imidazopyridazines
|
AR090548A1
(es)
|
2012-04-02 |
2014-11-19 |
Incyte Corp |
Azaheterociclobencilaminas biciclicas como inhibidores de pi3k
|
CA2869212A1
(en)
|
2012-04-04 |
2013-10-10 |
Bayer Pharma Aktiengesellschaft |
Amino-substituted imidazopyridazines
|
SI3243826T1
(sl)
|
2012-04-26 |
2020-03-31 |
Bristol-Myers Squibb Company |
Derivati imidazotiadiazola in imidazopirazina kot proteazno aktivirani receptor 4 (PAR4) inhibitorji za zdravljenje agregacije trombocitov
|
JP6042529B2
(ja)
|
2012-04-27 |
2016-12-14 |
ノバルティス アーゲー |
環式橋頭エーテルdgat1阻害剤
|
AU2013259384B2
(en)
|
2012-05-09 |
2016-06-02 |
Biogen Ma Inc. |
Nuclear transport modulators and uses thereof
|
EA024391B1
(ru)
|
2012-05-15 |
2016-09-30 |
Новартис Аг |
Производные бензамида для ингибирования активности abl1, abl2 и bcr-abl1
|
TW201406761A
(zh)
|
2012-05-18 |
2014-02-16 |
Incyte Corp |
做爲jak抑制劑之哌啶基環丁基取代之吡咯并吡啶及吡咯并嘧啶衍生物
|
EP2861585B1
(en)
|
2012-05-21 |
2019-01-09 |
Novartis AG |
Novel ring-substituted n-pyridinyl amides as kinase inhibitors
|
AP3913A
(en)
|
2012-05-22 |
2016-11-26 |
Idenix Pharamaceuticals Inc |
D-amino acid compounds for liver disease
|
TWI568722B
(zh)
|
2012-06-15 |
2017-02-01 |
葛蘭馬克製藥公司 |
作爲mPGES-1抑制劑之***酮化合物
|
EP2867232B1
(en)
|
2012-06-27 |
2018-08-08 |
F.Hoffmann-La Roche Ag |
5-azaindazole compounds and methods of use
|
TW201408652A
(zh)
|
2012-07-11 |
2014-03-01 |
Hoffmann La Roche |
作爲RORc調節劑之芳基磺內醯胺衍生物
|
TW201414737A
(zh)
|
2012-07-13 |
2014-04-16 |
必治妥美雅史谷比公司 |
作爲激酶抑制劑之咪唑并三□甲腈
|
WO2014022752A1
(en)
|
2012-08-03 |
2014-02-06 |
Amgen Inc. |
Macrocycles as pim inhibitors
|
WO2014033630A1
(en)
|
2012-08-31 |
2014-03-06 |
Novartis Ag |
Novel aminothiazole carboxamides as kinase inhibitors
|
WO2014033631A1
(en)
|
2012-08-31 |
2014-03-06 |
Novartis Ag |
N-(3-pyridyl) biarylamides as kinase inhibitors
|
CN103664878A
(zh)
|
2012-09-12 |
2014-03-26 |
山东亨利医药科技有限责任公司 |
杂芳环及其衍生物类酪氨酸激酶抑制剂
|
MX2015003364A
(es)
|
2012-09-14 |
2016-03-31 |
Abbvie Deutschland |
Derivados triciclicos de quinolinas y de quinoxalinas.
|
US9328106B2
(en)
|
2012-09-26 |
2016-05-03 |
Genentech, Inc. |
Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
|
WO2014053568A1
(en)
|
2012-10-02 |
2014-04-10 |
Sanofi |
Indolyldihydroimidazopyrimidinone derivatives, preparation thereof and therapeutic use thereof
|
AR093020A1
(es)
|
2012-10-16 |
2015-05-13 |
Janssen R&D Ireland |
Compuestos antiviricos para el vsr
|
EP2917221A1
(en)
|
2012-11-01 |
2015-09-16 |
Incyte Corporation |
Tricyclic fused thiophene derivatives as jak inhibitors
|
CA2891644A1
(en)
|
2012-11-19 |
2014-05-22 |
Bayer Pharma Aktiengesellschaft |
Aminoimidazopyridazines
|
WO2014079011A1
(en)
|
2012-11-22 |
2014-05-30 |
Agios Pharmaceuticals, Inc. |
Heterocyclic compounds for inhibiting glutaminase and their methods of use
|
EP3418281B1
(en)
|
2012-12-07 |
2020-09-30 |
Vertex Pharmaceuticals Inc. |
Pyrazolo[1,5-a]pyrimidines useful as inhibitors of atr kinase for the treatment of cancer diseases
|
BR112015014458B1
(pt)
|
2012-12-18 |
2022-06-21 |
Vertex Pharmaceuticals Incorporated |
Compostos derivados de manose, seus intermediários, composição, uso e processos de preparação
|
US20150336960A1
(en)
|
2012-12-19 |
2015-11-26 |
Novartis Ag |
Aryl-substituted fused bicyclic pyridazine compounds
|
US20140171404A1
(en)
|
2012-12-19 |
2014-06-19 |
Novartis Ag |
Autotaxin inhibitors
|
NZ718708A
(en)
|
2012-12-21 |
2018-11-30 |
Gilead Sciences Inc |
Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
|
UA118548C2
(uk)
|
2012-12-21 |
2019-02-11 |
Епізайм, Інк. |
Тетрагідро- та дигідроізохіноліни як інгібітори prmt5 та їх застосування
|
FR3000569B1
(fr)
|
2013-01-03 |
2015-02-13 |
Peugeot Citroen Automobiles Sa |
Dispositif d'eclairage a ecran a bord(s) lumineux
|
US9278950B2
(en)
|
2013-01-14 |
2016-03-08 |
Incyte Corporation |
Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors
|
BR122019024759B1
(pt)
*
|
2013-01-15 |
2022-02-08 |
Incyte Holdings Corporation |
Compostos de tiazolacarboxamidas e piridinacarboxamida, composição compreendendo os mesmos, método de inibição da enzima pim1, pim2, ou pim3, e usos dos referidos compostos
|
TWI687220B
(zh)
|
2013-03-01 |
2020-03-11 |
美商英塞特控股公司 |
吡唑并嘧啶衍生物治療PI3Kδ相關病症之用途
|
UA121532C2
(uk)
|
2013-03-06 |
2020-06-10 |
Інсайт Холдінгс Корпорейшн |
Способи і проміжні сполуки при отриманні інгібітора jak
|
JO3383B1
(ar)
|
2013-03-14 |
2019-03-13 |
Lilly Co Eli |
مثبطات cdc7
|
AR095443A1
(es)
|
2013-03-15 |
2015-10-14 |
Fundación Centro Nac De Investig Oncológicas Carlos Iii |
Heterociclos condensados con acción sobre atr
|
TWI742541B
(zh)
|
2013-03-15 |
2021-10-11 |
英商邊緣生物科技有限公司 |
用於治療肺纖維化、肝纖維化、皮膚纖維化及心臟纖維化之經取代之芳族化合物
|
US9308236B2
(en)
|
2013-03-15 |
2016-04-12 |
Bristol-Myers Squibb Company |
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
|
TWI689490B
(zh)
|
2013-03-15 |
2020-04-01 |
英商邊緣生物科技有限公司 |
用於治療纖維化之經取代之芳族化合物及相關方法
|
PE20151990A1
(es)
|
2013-03-15 |
2016-01-13 |
Incyte Corp |
Heterociclos triciclicos como inhibidores de la proteina bet
|
RU2680100C9
(ru)
|
2013-03-15 |
2019-04-18 |
Плексксикон Инк. |
Гетероциклические соединения и их применения
|
US20160052926A1
(en)
|
2013-03-15 |
2016-02-25 |
Hutchison Medipharma Limited |
Novel pyrimidine and pyridine compounds and usage thereof
|
CN105246477A
(zh)
|
2013-03-15 |
2016-01-13 |
全球血液疗法股份有限公司 |
化合物及其用于调节血红蛋白的用途
|
TW201522341A
(zh)
|
2013-03-15 |
2015-06-16 |
Respivert Ltd |
化合物
|
UY35421A
(es)
|
2013-03-15 |
2014-10-31 |
Nihon Nohyaku Co Ltd |
Compuesto heterocíclico condensado o su sal, insecticida agrícola u hortícola que comprende el comp uesto y método de uso del insecticida
|
US20140275108A1
(en)
|
2013-03-15 |
2014-09-18 |
Galderma Research & Development |
Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
|
MX2015011448A
(es)
|
2013-03-15 |
2016-06-06 |
Global Blood Therapeutics Inc |
Compuestos y sus usos para modular la hemoglobina.
|
CN109134440A
(zh)
|
2013-03-15 |
2019-01-04 |
美国陶氏益农公司 |
除草化合物及其作为除草剂的用途
|
NO2975028T3
(es)
|
2013-03-15 |
2018-07-21 |
|
|
JP6387361B2
(ja)
|
2013-03-15 |
2018-09-05 |
イドーシア ファーマシューティカルズ リミテッドIdorsia Pharmaceuticals Ltd |
ピリジン−4−イル誘導体
|
US9655854B2
(en)
|
2013-08-07 |
2017-05-23 |
Incyte Corporation |
Sustained release dosage forms for a JAK1 inhibitor
|
JP2016528298A
(ja)
|
2013-08-23 |
2016-09-15 |
インサイト・コーポレイションIncyte Corporation |
Pimキナーゼ阻害剤として有用なフロピリジン及びチエノピリジンカルボキシアミド化合物
|
MX2016011103A
(es)
|
2014-02-28 |
2017-02-28 |
Incyte Corp |
Inhibidores de cinasa janus 1 (jak1) para el tratamiento de sindromes mielodisplasicos.
|
RS61058B1
(sr)
|
2014-04-08 |
2020-12-31 |
Incyte Corp |
Lečenje b-ćelijskih maligniteta sa kombinacijom inhibitora jak i pi3k
|
SG10201809518QA
(en)
|
2014-04-30 |
2018-11-29 |
Incyte Corp |
Processes of preparing a jak1 inhibitor and new forms thereto
|
WO2015184305A1
(en)
|
2014-05-30 |
2015-12-03 |
Incyte Corporation |
TREATMENT OF CHRONIC NEUTROPHILIC LEUKEMIA (CNL) AND ATYPICAL CHRONIC MYELOID LEUKEMIA (aCML) BY INHIBITORS OF JAK1
|
WO2015191677A1
(en)
|
2014-06-11 |
2015-12-17 |
Incyte Corporation |
Bicyclic heteroarylaminoalkyl phenyl derivatives as pi3k inhibitors
|
US9580418B2
(en)
|
2014-07-14 |
2017-02-28 |
Incyte Corporation |
Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors
|
WO2016010897A1
(en)
|
2014-07-14 |
2016-01-21 |
Incyte Corporation |
Bicyclic heteroaromatic carboxamide compounds useful as pim kinase inhibitors
|
US9540347B2
(en)
|
2015-05-29 |
2017-01-10 |
Incyte Corporation |
Pyridineamine compounds useful as Pim kinase inhibitors
|
TWI734699B
(zh)
|
2015-09-09 |
2021-08-01 |
美商英塞特公司 |
Pim激酶抑制劑之鹽
|
US9920032B2
(en)
|
2015-10-02 |
2018-03-20 |
Incyte Corporation |
Heterocyclic compounds useful as pim kinase inhibitors
|